Identical ␤-lactamase-encoding (TEM-1) plasmids were found in two different clinical Neisseria meningitidis strains. They were completely sequenced (5,597 bp) and designated pAB6. The plasmid is almost identical to Neisseria gonorrhoeae plasmid pJD5 (5,599 kb) and may have been picked up from a gonococcus in vivo.
can be transferred in vitro to N. meningitidis by a conjugative plasmid (24.5 or 25.2 MDa) present in some strains of N. gonorrhoeae (6, 13, 14) . This probably also happens in vivo since both species occasionally coexist in the genitourinary tract (6) . The spread of penicillin resistance among strains of N. meningitidis can be monitored by examining the characteristics of the types of ␤-lactamase-encoding plasmids and the ␤-lactamase genes.
The aim of the present study was to sequence and identify the type of ␤-lactamase plasmids found in two strains of N. meningitidis isolated in Spain (19) . The ␤-lactamase-producing N. meningitidis strains MC9690-129 and MC9690-130 were isolated from the blood of a patient with meningitis and from the throat of a contact person, respectively. Both strains were B:4:P1.15 (19) . The strains were cultured on GC agar plates (3% GC medium base; Difco Laboratories) with 1% supplements (0.4% D-glucose, 0.01% L-glutamine, 0.1% cocarboxylase, and 0.5% ferric nitrate), 0.5% IsoVitaleX enrichment (BBL), and 0.5 mg of penicillin G/liter at 37°C in an atmosphere with 5% CO 2 for 18 to 20 h.
Antibiograms for the N. meningitidis strains were established with the E-test (Biodisk, Solna, Sweden) on chocolate Mueller-Hinton agar (9) . The MICs (in micrograms per milliliter) of penicillin G (1.0), penicillin V (3.0), ampicillin (3.0), piperacillin (0.032), oxacillin (24), piperacillin-tazobactam (Յ0.016), cefuroxime (0.38), ceftriaxone (Ͻ0.002), ceftazidime (0.023), imipenem (0.19), ciprofloxacin (0.004), rifampin (0.008), and chloramphenicol (0.75) for the two plasmid-carrying N. meningitidis strains were identical. The strains were tested for ␤-lactamase production by the chromogenic cephalosporin method (16), using nitrocefin discs (Biodisk, Solna, Sweden).
The tests were performed with aqueous suspensions of bacteria at room temperature, and the results were noted after 10 to 15 min and compared with those of positive and negative controls. Both strains were confirmed as ␤-lactamase producers.
The Wizard Plus Midipreps DNA purification system (Promega) and the QIAprep Spin Miniprep kit (Qiagen GmbH, Hilden, Germany) were used to prepare plasmid DNA. Plasmid DNA was digested with XbaI and PvuII, and the TEM fragment was ligated into the M13mp18/19 vectors (Pharmacia, Biotech, Uppsala, Sweden) according to the manufacturer's instructions. The recombinant DNA was transformed into E. coli JM105, which was cultured according to the manufacturer's instructions (Pharmacia Biotech).
Sequencing was performed with the ABI PRISM BigDye Terminator cycle sequencing system, using a Ready Reaction kit, on an ABI PRISM 310 genetic analyzer according to the manufacturer's instructions (Perkin-Elmer Applied Biosystems). The TEM gene sequence was determined by direct sequencing of the clones. The complete primer sequence was then determined by primer walking.
The nucleotide sequences of the two plasmids were determined and compared to each other and to registered sequences in the international databases GenBank, European Molecular Biology Laboratory (EMBL), DNA Data Bank of Japan (DDBJ), and Protein Data Bank (PDB) by BLAST search (http://www.ncbi.nlm.nih.gov). The comparisons between the two plasmids showed that they had identical DNA sequences of 5,597 bp. Thus, the same plasmid was found in the two strains, and it was designated pAB6. The sequence of pAB6 was almost identical in size to pJD5 and in sequence to the major part of pJD4 (accession no. U20374) (5, 14) (which probably corresponds to pJD5), as well as to the databasereported region in pJD5 flanking the deletion site (883 bp; accession no. U20375) (Fig. 1) ; the only base differences between pJD4/pJD5 and pAB6 were at bp 442 (A3G) and bp 3369 (G3T). Open reading frames for four proteins were identified from the gene sequence ( Fig. 1) : one for a transposon Tn2 resolvase, TnpR (a variant of the reported Tn3 resolvase [3] ), at bp 506 (5Ј) to bp 907 (3Ј) (accession no. P03011); one for a TEM-1 ␤-lactamase at bp 1090 (5Ј) to bp 1950 (3Ј) (accession no. P00810); one for a DNA replication protein at bp 2252 (3Ј) to bp 3238 (5Ј) (accession no. P17492); and one for a plasmid mobilization protein at bp 4363 (5Ј) to bp 42 (3Ј) (accession no. P07112). The TEM-1 ␤-lactamase gene was found to be identical to that in pJD4/pJD5, which is the same as that in Tn2. Two differences between pAB6 and Tn2 were seen: C3T at base 913 and A3T at base 439 on pAB6, identical to base switches at positions 3773 and 3299, respectively, on Tn2 in the 4.4-MDa plasmid (pJD4; 7.4 kb) (3, 4 ). An inverted repeat, IR1 (AACCCTTAAAGAACTCGCA ACAAGTTGCAAATTCTTTAAGGGTT), was also identified, identical to the one in pJD4. Deletion site-flanking repeats, r1 (AACAGGAAATTTGTTGTCTTAT), 1r (3Ј-5Ј) (TATTCTGTTGTTTAAAGGACAA), and r2 (CTTTTTTG GGCTTTCAGCCCTAATTTTTTCTTTTTTCAGGAATTA A), were identified as well, identical to the repeats found on pJD4/pJD5.
Conclusions. In the present study, two ␤-lactamase plasmids isolated from N. meningitidis were completely sequenced for the first time; they were found to be identical and designated pAB6 (Fig. 1) . The sizes and sequences of pAB6 and pJD5 (5, 7) as seen with pJD4 [ Fig. 1]) are almost identical. pAB6 could thus be a variant of pJD5 picked up from a gonococcus in vivo.
If these types of pathogenic meningococcal strains harboring plasmids like pAB6 become common, they will cause problems for the treatment of meningococcal meningitis and septicemia. Therefore, it appears to be important to evaluate N. meningitidis strains regularly for any changes in susceptibility patterns and for the introduction of ␤-lactamase plasmids.
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